s-adenosylmethionine has been researched along with fenretinide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asara, G; Brignole, C; Calvisi, DF; De Miglio, MR; Feo, F; Frau, M; Muroni, MR; Pagnan, G; Pascale, RM; Pastorino, F; Ponzoni, M; Seddaiu, MA; Simile, MM | 1 |
1 other study(ies) available for s-adenosylmethionine and fenretinide
Article | Year |
---|---|
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Transformation, Neoplastic; Cyclin D1; Fenretinide; I-kappa B Proteins; Liposomes; Liver; Liver Neoplasms; Male; Methionine Adenosyltransferase; NF-KappaB Inhibitor alpha; NF-kappaB-Inducing Kinase; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred F344; S-Adenosylmethionine; Vascular Endothelial Growth Factor A | 2005 |